Drägerwerk stock falls 1.45% as quarterly margins tighten
Published on 11/09/2026 at 18:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSSales Growth Meets Margin Pressure
- Currency-adjusted nine-month sales increased, while third-quarter EBIT declined from the prior-year quarter.
- Customs refunds supported nine-month EBIT, making the quality of the earnings improvement important for investors.
- Drägerwerk reaffirmed its 2026 targets and plans a Capital Markets Day for November 18 in Lübeck.
Drägerwerk reported stronger sales for the first nine months of 2026 on October 29, but third-quarter profitability weakened. The Yahoo Finance earnings call transcript shows that currency-adjusted net sales rose 5.3 percent to around 2.5 billion euros in the nine-month period, while EBIT increased to around 112 million euros.
Quarterly Profitability Remains In Focus
In the third quarter, net sales were 1 percent above the prior-year quarter, but EBIT fell to around 48 million euros from around 57 million euros. The EBIT margin narrowed to around 5.6 percent from 6.8 percent. Management said nine-month EBIT included 27.9 million euros in customs refunds, including 20.1 million euros attributable to the third quarter.
Both divisions contributed to the nine-month sales advance. Safety Technology recorded stronger order momentum, while Medical Technology continued to face pressure in parts of its order book. Management also pointed to higher personnel, logistics and IT costs, keeping cost control central to the final quarter.
Outlook And Next Investor Date
Drägerwerk confirmed its 2026 guidance for currency-adjusted sales growth of 2 to 6 percent and an EBIT margin of 6 to 8 percent. The company also expects to present its Ambition 2030 at a Capital Markets Day in Lübeck on November 18.
Drägerwerk stock traded at 102.20 euros on Lang & Schwarz at 17:59 Berlin time on Monday, November 9, 2026, 1.45 percent below the 103.70-euro level in the latest relevant report published on November 6. The quote was 0.39 percent above the Xetra close of Monday, November 9, at 101.80 euros.
Drägerwerk AG & Co. KGaA
- ISIN: DE0005550636
- Xetra ticker: DRW3
- Lang & Schwarz quote: 102.20 euros on November 9, 2026, at 17:59 Berlin time
- Change since latest relevant report: minus 1.45 percent from 103.70 euros on November 6, 2026
- Xetra close: 101.80 euros on November 9, 2026
Market conditions for German equities can be followed in the DAX market overview.
More news and analyses are available on the Drägerwerk stock topic page.
